Anaplastic Oligodendroglioma - 228 Studies Found
Completed |
: Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Recurrent Malignant Glioma :
: |
Suspended |
: Viral Therapy in Treating Patients With Recurrent Glioblastoma Multiforme :
: |
Active, not recruiting |
: Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain Tumor :
|
Active, not recruiting |
: Study of a Retroviral Replicating Vector to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor :
|
Terminated |
: Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas :
|
Active, not recruiting |
: Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor :
: |
Completed |
: Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms :
: |
Active, not recruiting |
: Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas :
|
Withdrawn |
: Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant Glioma :
|
Completed |
: Sorafenib in Newly Diagnosed High Grade Glioma :
: Drug: Sorafenib dose escalation Sorafenib dose escalation scheme: 3 first patients: 200 mg/d, if dose li |